Just before the 23andMe SPAC deal closed, the stock belonging to its merger partner ... giving investors the impression it is a risk-free investment. Some companies do not find appropriate acquisition ...

Me’s debacle should be a major wake-up call, reminding policymakers and all of us of the risks of giving access to our ...

23andme says it owns the aggregated genetic data of its customers, meaning it can sell it to the highest bidder ...

A U.S. House committee on Tuesday asked 23andMe's co-founder to testify next month as it launched an investigation into the ...

Me on Sunday filed for bankruptcy in the U.S. after struggling with weak demand for its ancestry testing kits and a 2023 data ...

DNA testing pioneer 23andMe filed ... would love to see a space where people can get the information they want without feeling as though that information might put them at risk,” Cohen said.

DNA-testing company 23andMe has filed for bankruptcy, which means the future of the company’s vast trove of customer data is ...

23andMe is going bankrupt — underscoring the great risks of investing in many of the companies that have gone public via mergers with special-purpose acquisition corporations. When companies opt ...

Just before the 23andMe SPAC deal closed, the stock belonging to ... giving investors the impression it is a risk-free investment. Some companies do not find appropriate acquisition targets ...

23andMe bankruptcy underscores the risk of investing in most SPACs ... whose mission is to make acquisitions. Then the SPAC converts its ticker symbol and name over to one matching the name ...